View Single Post
Old 09-21-2013, 11:59 AM   #1
Senior Member
'lizbeth's Avatar
Join Date: Apr 2008
Location: Sunny San Diego
Posts: 2,214
Post First line Treatment - Perjeta for MBC

322 study sites - internationally (outside of the US)

A Study of Pertuzumab in Combination With Herceptin (Trastuzumab) and A Taxane in First-Line Treatment in Patients With HER2-Positive Advanced Breast Cancer (PERUSE) Identifier:
'lizbeth is offline   Reply With Quote